“DCGI has made it mandatory for all manufacturers and importers who have obtain new drug permission to submit Periodic Safety Update Reports of new drug every six months for the first two year and for the subsequent two years it should be submitted annually”.
One of the most consequential decisions a Medical Device company faces when entering the Indian manufacturing landscape is whether to establish its own licensed manufacturing facility or to operate un..
Time Is Money — And Preventable Delays Are Common India’s Biological product approval timelines are frequently longer than companies anticipate. While CDSCO has made significant progress in re..
Private equity investment in India’s Pharmaceutical sector has accelerated substantially. The combination of a large domestic market, globally competitive manufacturing, and India’s strate..
India
Global
Sales: +91 7672005050
Reception: +91-11-45214546
9 am to 6 pm (Monday to Friday)